Clinical characteristics and risk score for poor clinical outcome of acute ischemic stroke patients treated with intravenous thrombolysis therapy

被引:10
|
作者
Yue, Yun-hua [1 ]
Li, Zhi-zhang [1 ]
Hu, Liang [1 ]
Zhu, Xiao-qiong [1 ]
Xu, Xu-shen [1 ]
Sun, Hong-xian [1 ]
Wan, Zhi-wen [1 ]
Xue, Jie [1 ]
Yu, De-hua [2 ]
机构
[1] Tongji Univ, Dept Neurol, Yangpu Hosp, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Dept Gen Med, Yangpu Hosp, Sch Med, Shanghai, Peoples R China
来源
BRAIN AND BEHAVIOR | 2019年 / 9卷 / 04期
关键词
outcome; stroke; tissue plasminogen activator; C-REACTIVE PROTEIN; BLOOD-PRESSURE; HYPERGLYCEMIA; HEMORRHAGE; PREDICTION; MORTALITY; DAMAGE; SCALE;
D O I
10.1002/brb3.1251
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background Tissue plasminogen activator (t-PA) is an effective therapy for acute ischemic stroke, but some patients still have poor clinical outcome. In this study, we investigated clinical characteristics of stroke patients and determined predictors for poor clinical outcome in response to t-PA treatment. Methods Clinical data from 247 patients were retrospectively reviewed. Clinical parameters that were associated with survival of patients were analyzed. Areas under receiver operating characteristic curves (ROC) were used to determine the feasibility of using various combinations of the clinical parameters to predict poor clinical response. The clinical outcome was defined according to the changes in Modified Rankin Scale. Results Overall, 145 patients had improved/complete recovery, 73 had no change, and 29 had worsening conditions or died during the in-clinic period. A univariate analysis showed that baseline characteristics including age, CRP, blood glucose level, systolic blood pressure, and admission NIHSS were significantly different (p 0.05) among patients with different clinical outcome. A further multivariate analysis was then performed. Variables associated with poor clinical outcome (worsening/death) (p < 0.1) were included in the logistic regression model. Four parameters were retained in the model: Age, CRP, Blood glucose level, and Systolic blood pressure (ACBS). To allow a convenient usage of the ACBS classifier, the parameters were put into a scoring system, and the score at 7.7 was chosen as a cut-off. The ROC curve of this ACBS classifier has an area under the curve (AUC) of 0.7788, higher than other individual parameters. The ACBS classifier provided enhanced sensitivity of 69.2% and specificity of 74.3%. Conclusion The ACBS classifier provided a satisfactory power in estimating the patients' clinical outcome. After further validating, the classifier may provide important information to clinicians for making clinical decisions.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Malnutrition and Risk of Mortality in Ischemic Stroke Patients Treated With Intravenous Thrombolysis
    Tang, Haiyan
    Gong, Fan
    Guo, Hongquan
    Dai, Zheng
    Wang, Jun
    Liu, Bin
    Li, Tingting
    Tang, Xianbiao
    Dong, Junru
    Pan, Song
    Wang, Mingzhe
    Sun, Yan
    Qin, Baofeng
    Zhang, Jingsi
    Zhu, Xuyin
    Tian, Jun
    Fei, Zhimin
    Lu, Gendi
    Liu, Dezhi
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [32] The clinical effect of urokinase intravenous thrombolysis in the treatment of acute ischemic stroke
    Li, N.
    Yu, F. Q.
    Cheng, Q. F.
    Feng, D. P.
    Chen, T. Z.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 186 - 186
  • [33] A Clinical Observation of Intravenous Thrombolysis in Acute Ischemic Stroke with Minor Trauma
    Cui, Yansen
    Wang, Liquan
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1983 - 1987
  • [34] Intravenous thrombolysis of acute ischemic stroke Five years clinical experience
    Andonova, S.
    Kalevska, E.
    Dimitrova, T.
    Petkova, M.
    Argirova, V.
    Tzvetkov, T.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 72 - 72
  • [35] Intravenous Thrombolysis in Acute Ischemic Stroke Five Years of Clinical Experience
    Andonova, S.
    Kalevska, E.
    Dimitrova, Tz.
    Petkova, M.
    Argirova, V.
    Tzvetkov, Tz.
    Georgieva, D.
    [J]. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, 2014, 10 (01): : 23 - 31
  • [36] Persistent contrast is a Predictor of Poor Clinical Outcome in Acute Stroke Patients Treated with Intrarterial Therapy
    Pagola, Jorge
    Rubiera, Marta
    Coscojuela, Pilar
    Rodriguez-Luna, David
    Pineiro, Socorro
    Maisterra, Olga
    Alvarez-Sabin, Jose
    Romero, Francisco
    Molina, Carlos. A.
    Ribo, Marc
    [J]. STROKE, 2011, 42 (03) : E228 - E228
  • [37] Acute Ischemic Stroke in Late Pregnancy Treated with Intravenous Thrombolysis and Endovascular Therapy
    Kristiansen, Eva Szuchy
    Vestergaard, Hannah Holm
    Modrau, Boris
    Oppel, Lorenz Martin
    [J]. CASE REPORTS IN NEUROLOGY, 2019, 11 (01) : 41 - 46
  • [38] Clinical Significance and Dynamic Change of Coagulation Parameters in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
    Li, Guangshuo
    Wang, Chuanying
    Wang, Shang
    Hao, Yahui
    Xiong, Yunyun
    Zhao, Xingquan
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [39] Clinical Significance and Dynamic Change of Coagulation Parameters in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
    Li, Guangshuo
    Wang, Chuanying
    Wang, Shang
    Hao, Yahui
    Xiong, Yunyun
    Zhao, Xingquan
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [40] Rate, Clinical features, Safety Profile and Outcome of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Negative Brain Imaging
    Mowla, Ashkan
    Kamal, Haris
    Mehla, Sandhya
    Shirani, Peyman
    Singh, Karanbir
    Farooq, Salman
    Crumlish, Annmarie
    Ching, Marilou
    Sawyer, Robert N.
    [J]. STROKE, 2015, 46